ArticleCancer science2019

Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.

Mao-Bin Meng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.